MOUNTAIN VIEW, Calif., Feb. 25, 2011 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at three investment conferences during the month of March.
The conference presentation schedule is as follows: | ||
Citi’s 2011 Global Health Care Conference | ||
March 1, 2011 at 4:00 p.m. ET | ||
Hilton New York Hotel, New York, NY | ||
Cowen and Company 31st Annual Health Care Conference | ||
March 8, 2011 at 8:45 a.m. ET | ||
The Boston Marriott Copley Place, Boston, MA | ||
ROTH Capital Partners 23rd Annual OC Growth Stock Conference | ||
March 15, 2011 at 11:30 a.m. PT | ||
Ritz-Carlton, Laguna Niguel, CA | ||
A live audio webcast and 30-day archive of the presentations will be available at http://ir.vivus.com.
About VIVUS
VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company’s lead product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. QNEXA® is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com.
CONTACT: | |||
VIVUS, Inc. | Investor Relations: | The Trout Group | |
Timothy E. Morris | Brian Korb | ||
Chief Financial Officer | bkorb@troutgroup.com | ||
650-934-5200 | 646-378-2923 | ||
SOURCE VIVUS, Inc.
